Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04570579 · ClinicalTrials.gov registry record
Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement
A clinical trial of Cataract and Presbyopia, sponsored by Alanna Nattis, DO.
- Active
- Registry status
- 46
- Enrollment target
- 1
- Study location
NCT04570579 is a study of Cataract and Presbyopia that is active but no longer recruiting, run by Alanna Nattis, DO. The registered enrollment target is 46 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04570579, a study of Cataract and Presbyopia, is active but no longer recruiting, sponsored by Alanna Nattis, DO.
- ACTIVE NOT RECRUITING
- Registry status
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The introduction of presbyopia-correcting intraocular lenses (PC-IOLs) has provided cataract and refractive surgeons the ability to provide patients with a wider range of visual success and spectacle independence post-cataract surgery.Multifocal (MFIOL) IOLs have the ability to provide near and distance vision, and in the case of trifocal IOLs, near, intermediate and distance. Despite the significant technological evolution of MFIOL's, the potential for visual disturbances, such as glare, halos and starbursts still exists-and in much greater frequency compared to their monofocal counterparts. Extended depth of focus (EDOF) IOLs aim to provide patients with a functional range of vision, with a similar visual disturbance profile to a monofocal lens. In this way, this subset of PC-IOL's can offer patients some degree of spectacle independence, with a significantly lower incidence of visual disturbances. The Vivity Extended Vision IOL is the first of its kind to offer Wavefront Stretching technology, providing patients with an excellent extended range of vision from intermediate to distance, as well as some functional near vision. Prior studies have demonstrated very good vision in both bright and dim lighting conditions, as well as a high degree of spectacle independence with the Vivity IOL, as compared to a monofocal IOL. Studies evaluating the ability of the Vivity IOL to provide a significant impact on patient lifestyle (e.g. patient independence from spectacles for most activities with a low rate of visual disturbances) in the United States in a 'real-world' setting have yet to be performed. In addition, influence of pre-and-perioperative variables such as sex, age, prior refractive surgery, IOL formula used, axial length, astigmatism, use of intraoperative aberrometry, femtosecond laser and pupillary expansion devices has yet to be evaluated on the postoperative success of this IOL. This study will be comprised of patients with visually significant cataracts w
Conditions Studied
Interventions
- DEVICE Vivity Extended Depth of Focus Intraocular Lens
Study Locations (1)
New York
- SightMD - Babylon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2020-10-14 |
| Est. Completion | 2025-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04570579
The ClinicalTrials.gov registry entry for NCT04570579 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (80% lower). The listed sponsor is Alanna Nattis, DO, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Vivity Extended Depth of Focus Intraocular Lens is the first listed.
NCT04570579 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04570579 about?
NCT04570579 is a clinical study titled "Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement". The introduction of presbyopia-correcting intraocular lenses (PC-IOLs) has provided cataract and refractive surgeons the ability to provide patients with a wider range of visual success and spectacle independence post-cataract surgery.Multifocal (MFIOL) IOLs have the ability to provide near and dist...
What is the current status of trial NCT04570579?
This trial is currently active not recruiting. The enrollment target is 46 participants. The study started on 2020-10-14. Estimated completion is 2025-12-30.
What conditions does trial NCT04570579 study?
This clinical trial studies the following conditions: Cataract, Presbyopia, Cataract Senile.
What interventions are being tested in trial NCT04570579?
The interventions under investigation include: Vivity Extended Depth of Focus Intraocular Lens (DEVICE).
Who is sponsoring clinical trial NCT04570579?
This trial is sponsored by Alanna Nattis, DO, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04570579 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence Tomography
RECRUITING
-
Effective Phaco Time and Endothelial Cell Loss When Using Veritas
RECRUITING
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
RECRUITING · Phase 1
-
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
RECRUITING · Phase 3
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.